Anti-Tumor Effects of Adoptively Transferred Splenocytes Induced by Ehcgβ Gene Immunization

关庆东,王立新,张进平,徐薇,储以微,王缨,熊思东

DOI: https://doi.org/10.3872/j.issn.1007-385x.2004.02.001

2004-01-01

Chinese Journal of Cancer

Abstract:Objective: To investigate the anti-tumor effects of adoptively transferred splenocytes induced by gene immunization with ehCGβ tumor vaccine. Methods: Sp2/0 cells were transfected with the plasmids containing ehCGβ or HBV-preS2/S and the postive clones were screened by G418. BALB/c mice were immunized with plasmid TR421-hCGβ or mock DNA three times. Two weeks after immunization, spleen cells from the immunized mice were harvested, and then analyze the CTL activity against Sp2/0-ehCGβ cells. The splenocytes derived from the immunized mice were adoptively transferred to the normal mice, which were subsequently given injections i. p. of Sp2/0-ehCGβ and β Sp2/0-preS2/S respectively. Results: Splenocytes derived from the mice immunized with TR421-hCGp exhibited a strong specfic cytotoxic activity against Sp2/0-ehCGβ cells, The average tumor weight between test and control group is statistically significant ( P 0. 05 ) . Only two mice out of six had tumors in Sp2/0-ehCGβadoptively transferred group, while all mice had tumors in control group. However, all mice challenged with Sp2/0-preS2/S formed tumors, and the average tumor weight was not obviously varied between the two groups. Conclusion: ehCGβ gene vaccine could induce specific cytotoxic splenocytes a-gainst ehCGβ and adoptive transfer of the splenocytes showed the anti-tumor activity.